# Nan Fung Group Holdings Ltd: Form 13F holdings

An institutional investment manager in KAI TAK. SEC CIK 1782539.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $131.5m
- Positions: 25 (25 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1782539/000101297526000761/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [MAPLIGHT THERAPEUTICS INC (MPLT)](/companies/mplt.md) | COM | $34.8m | 26.5% | 971,253 |  | Unchanged |
| [LB PHARMACEUTICALS INC (LBRX)](/companies/lbrx.md) | COM SHS | $20.5m | 15.6% | 630,657 |  | Unchanged |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $19.2m | 14.6% | 1,441,032 |  | Unchanged |
| CYBIN INC | COM NEW | $6.5m | 5.0% | 987,222 |  | Added +527,222 |
| [INCYTE CORP (INCY)](/companies/incy.md) | COM | $6.1m | 4.6% | 53,742 |  | Unchanged |
| [RHYTHM PHARMACEUTICALS INC (RYTM)](/companies/rytm.md) | COM | $5.5m | 4.1% | 49,120 |  | Unchanged |
| [BEONE MEDICINES LTD (ONC)](/companies/onc.md) | SPONSORED ADS | $4.5m | 3.4% | 15,722 |  | Unchanged |
| OCULIS HOLDING AG | ORDINARY SHARES | $4.2m | 3.2% | 300,565 |  | Reduced −50,180 |
| ASCENDIS PHARMA A/S | ORD SHS | $3.6m | 2.8% | 13,600 |  | New +13,600 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $3.6m | 2.7% | 19,253 |  | Unchanged |
| [KYMERA THERAPEUTICS INC (KYMR)](/companies/kymr.md) | COM | $3.5m | 2.7% | 30,875 |  | Unchanged |
| [MADRIGAL PHARMACEUTICALS INC (MDGL)](/companies/mdgl.md) | COM | $3.0m | 2.3% | 5,672 |  | Unchanged |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $3.0m | 2.3% | 28,300 |  | Unchanged |
| [ACADIA PHARMACEUTICALS INC (ACAD)](/companies/acad.md) | COM | $2.6m | 2.0% | 102,984 |  | Unchanged |
| [ARGENX SE (ARGX)](/companies/argx.md) | SPONSORED ADR | $2.6m | 2.0% | 2,800 |  | Unchanged |
| [RECURSION PHARMACEUTICALS IN (RXRX)](/companies/rxrx.md) | CL A | $2.2m | 1.7% | 595,287 |  | Unchanged |
| [PROCORE TECHNOLOGIES INC (PCOR)](/companies/pcor.md) | COM | $2.2m | 1.6% | 53,299 |  | Unchanged |
| [HARMONY BIOSCIENCES HLDGS IN (HRMY)](/companies/hrmy.md) | COM | $984.9k | 0.7% | 27,049 |  | Unchanged |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $701.6k | 0.5% | 6,580 |  | Unchanged |
| ISHARES ETHEREUM TR | SHS | $601.0k | 0.5% | 50,549 |  | Unchanged |
| [ISHARES BITCOIN TRUST ETF (IBIT)](/companies/ibit.md) | SHS BEN INT | $531.6k | 0.4% | 15,968 |  | Unchanged |
| [CHIME FINL INC (CHYM)](/companies/chym.md) | COM SHS CL A | $431.6k | 0.3% | 21,075 |  | New +21,075 |
| [RANI THERAPEUTICS HLDGS INC (RANI)](/companies/rani.md) | COM CL A | $375.3k | 0.3% | 493,584 |  | Unchanged |
| [ENTRADA THERAPEUTICS INC (TRDA)](/companies/trda.md) | COM | $361.2k | 0.3% | 49,082 |  | Unchanged |
| [BOLT BIOTHERAPEUTICS INC (BOLT)](/companies/bolt.md) | COM NEW | $19.3k | <0.1% | 5,000 |  | Reduced −24,250 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $0 | 0.0% | 0 |  | Sold out −13,600 |

Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000761. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.